Connections Seelos Therapeutics, Inc.

SEELQ

US81577F4063

Biotechnology & Medical Research

Delayed OTC Markets 12:25:32 2026-06-01 EDT			5-day change	1st Jan Change
0.000100 ^USD	+9,900.00%		-.--%	+9,900.00%

12-28	Motion for Asset Sale Approved for Seelos Therapeutics, Inc.	CI
25-10-21	GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q).	CI

5

Listed companies

0

Private companies

20

Insiders

Relation chart of related listed companies: Seelos Therapeutics, Inc.

Active Relations

Past Relations

Related listed companies: Seelos Therapeutics, Inc.

DIAMEDICA THERAPEUTICS INC.

Daniel O'Connor

VIKING THERAPEUTICS, INC.

ARS PHARMACEUTICALS, INC.

Brian Dorsey

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Pharmaceuticals: Major	3
Biotechnology	2

Countries of related companies

United States

Seelos Therapeutics, Inc. has ongoing preclinical programs, including SLS-004, SLS-006, and SLS-007. It has filed a voluntary petition under chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York.

Employees

Sector

Biotechnology & Medical Research

More about the company